Late Gadolinium Enhancement-cardiovascular Magnetic Resonance As a Predictor of Response to Cardiac Resynchronization Therapy in Patients with Ischaemic Cardiomyopathy
Overview
Physiology
Authors
Affiliations
Aim: To determine whether myocardial scarring, quantified using late gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR), predicts response to cardiac resynchronization therapy (CRT).
Methods And Results: A total of 45 patients with ischaemic cardiomyopathy [age 67.1 +/- 10.4 years (mean +/- SD)] underwent assessment of 6 min walking distance (6MWD) and quality of life (QoL) before and after CRT. Scar size (percentage of left ventricular mass), location, and transmurality were assessed prior to CRT using LGE-CMR. Responders (survived for 1 year with no heart failure hospitalizations, and improvement by >or=1 NYHA classes or >or=25% 6MWD) had a higher left ventricular ejection fraction (P = 0.048), smaller scars (<33%) (P = 0.009), and fewer scars with >or=51% transmurality (P = 0.002). Scar size correlated negatively with change in 6MWD (r = -0.54, P < 0.001) and positively with changes in QoL scores (r = 0.35, P = 0.028). Responder rates in patients with <33% scar were higher than in those with >or=33% scar (82 vs. 35%, P < 0.01). Responder rates in patients with scar transmurality <51% were higher than in those with >or=51% (89 vs. 46%, P < 0.01). Among the patients with posterolateral scars, a transmurality value of >or=51% was associated with a particularly poor response rate (23%), compared with scars with <51% transmurality (88%, P < 0.001). In multivariate analyses, both scar size (P = 0.022) and transmurality (P = 0.004) emerged as predictors of response. In patients with posterolateral scars, pacing outside the scar was associated with a better responder rate than pacing over the scar (86 vs. 33%, P = 0.004).
Conclusions: In patients with ischaemic cardiomyopathy, a scar size >or=33%, a transmurality >or=51%, and pacing over a posterolateral scar are associated with a suboptimal response to CRT.
Feasibility and Role of Cardiac Magnetic Resonance in Intensive and Acute Cardiovascular Care.
Leo I, Figliozzi S, Ielapi J, Sicilia F, Torella D, Dellegrottaglie S J Clin Med. 2025; 14(4).
PMID: 40004642 PMC: 11856486. DOI: 10.3390/jcm14041112.
Stoiculescu F, Hadareanu D, Hadareanu C, Donoiu I, Florescu C Front Cardiovasc Med. 2025; 11:1406899.
PMID: 39744205 PMC: 11688290. DOI: 10.3389/fcvm.2024.1406899.
Khatun N, Sanchez-Nadales A, Francois J, Hussein M, Atere M, Rodriguez Y J Innov Card Rhythm Manag. 2024; 15(11):6095-6106.
PMID: 39563991 PMC: 11573304. DOI: 10.19102/icrm.2024.15111.
Meier C, Eisenblatter M, Gielen S J Cardiovasc Dev Dis. 2024; 11(2).
PMID: 38392254 PMC: 10888577. DOI: 10.3390/jcdd11020040.
Dokuchaev A, Chumarnaya T, Bazhutina A, Khamzin S, Lebedeva V, Lyubimtseva T Front Physiol. 2023; 14:1162520.
PMID: 37497440 PMC: 10367108. DOI: 10.3389/fphys.2023.1162520.